BAIN CAPITAL INVESTORS LLC

SEC Form 4 insider trading activity

BAIN CAPITAL INVESTORS LLC has filed 4 SEC Form 4 filings (8 transaction rows) across 2 companies, including KLRA, BOBS, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.

On the most recent filing, BAIN CAPITAL INVESTORS LLC is listed as 10% Owner at Kailera Therapeutics, Inc. Inside the rolling window, BAIN CAPITAL INVESTORS LLC reported 1 open-market purchase totaling $134.4M in KLRA and 1 open-market sale totaling $46.5M in BOBS. The largest disclosed transaction in the window is a purchase of 8,398,438 KLRA shares on Apr 20, 2026, worth $134.4M.

Companies traded

Other insiders at KLRA

Insider Buying

$134.4M

reported purchases (SEC code P)

Insider Selling

$46.5M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
KLRAPurchase$134.4MApr 20SEC ↗
BOBSSale$46.5MFeb 13SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Nov 7, 2025COHRSale$1.1B
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BAIN CAPITAL INVESTORS LLC made?

BAIN CAPITAL INVESTORS LLC has filed 4 SEC Form 4 filings (8 transaction rows) across 2 companies, including KLRA, BOBS since 2025.

Which companies does BAIN CAPITAL INVESTORS LLC trade?

BAIN CAPITAL INVESTORS LLC has filed SEC Form 4 disclosures for 2 companies, including KLRA, BOBS.

When was BAIN CAPITAL INVESTORS LLC's most recent SEC Form 4 filing?

BAIN CAPITAL INVESTORS LLC's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.

What is BAIN CAPITAL INVESTORS LLC's total buy and sell value in the current window?

Inside the rolling retention window, BAIN CAPITAL INVESTORS LLC bought $134.4M and sold $46.5M based on SEC Form 4 filings.

What was BAIN CAPITAL INVESTORS LLC's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 8,398,438 KLRA shares on 2026-04-20, worth $134.4M, per SEC Form 4 filings.